{"transactions":[{"id":1042703,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-09-11T22:14:55.000Z","date":"2025-09-09","kind":"grant","planned":false,"acquired":true,"shares":17600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended, which vest in twelve equal monthly installments, beginning on the date of the grant."}],"balance_after":17600,"derivative":{"exercise_price":3.61,"expiration_date":"2035-09-09","underlying":"Common Stock","underlying_shares":17600},"source":{"system":"sec-edgar","filing":"0001411685-25-000075","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141168525000075/edgardoc.xml","form_type":"4"}},{"id":1410712,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-10T21:00:12.000Z","date":"2024-09-06","kind":"grant","planned":false,"acquired":true,"shares":14100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options (\"Options\") granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended. Twenty-five percent (25%) of the Options vest on the date of issuance (\"Grant Date\"), with the remainder vesting in twelve (12) equal monthly installments thereafter, until the Options become fully vested on the one (1) year anniversary of the Grant Date."}],"balance_after":14100,"derivative":{"exercise_price":3.25,"expiration_date":"2034-09-06","underlying":"Common Stock","underlying_shares":14100},"source":{"system":"sec-edgar","filing":"0001415889-24-023147","document":"form4-09102024_050907.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588924023147/form4-09102024_050907.xml","form_type":"4"}},{"id":1591376,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-06T23:00:15.000Z","date":"2024-03-04","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended, which vest in twelve equal monthly installments, beginning on the date of the grant."}],"balance_after":12500,"derivative":{"exercise_price":4.85,"expiration_date":"2034-03-04","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001415889-24-007096","document":"form4-03062024_060307.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588924007096/form4-03062024_060307.xml","form_type":"4"}},{"id":1798319,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2023-08-23T21:57:54.000Z","date":"2023-08-21","kind":"sale","planned":true,"acquired":false,"shares":1490,"price":16.6558,"value":24817.142,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units pursuant to an election intended to satisfy the conditions of Rule 10b5-1(c) made by the Reporting Person on September 9, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $16.65 to $16.87, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes shares acquired under the Issuer's Employee Stock Purchase Plan on September 13, 2022 for 448 shares, and on March 13, 2023 for 1,183 shares."}],"balance_after":26962,"source":{"system":"sec-edgar","filing":"0001209191-23-047103","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919123047103/doc4.xml","form_type":"4"}},{"id":2006257,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-02-17T21:12:44.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48 of the total stock option will vest and become exercisable monthly on the same day of each month following February 15, 2023, subject to continuous service of the Reporting Person on each vesting date."}],"balance_after":150000,"derivative":{"exercise_price":7.87,"expiration_date":"2033-02-14","underlying":"Class A Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-23-010542","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919123010542/doc4.xml","form_type":"4"}},{"id":2080876,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-12-19T22:01:33.000Z","date":"2022-12-16","kind":"exercise","acquired":false,"shares":2212,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4 of the shares subject to the option vested on December 16, 2021, and 1/48 of the shares vest monthly thereafter."}],"balance_after":35801,"derivative":{"exercise_price":2.8968,"expiration_date":"2030-12-15","underlying":"Class A Common Stock","underlying_shares":2212},"source":{"system":"sec-edgar","filing":"0001209191-22-061973","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122061973/doc4.xml","form_type":"4"}},{"id":2080875,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-12-19T22:01:33.000Z","date":"2022-12-16","kind":"sale","acquired":false,"shares":783,"price":20.1697,"value":15792.8751,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 13, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $20.06 to $20.515, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":26821,"source":{"system":"sec-edgar","filing":"0001209191-22-061973","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122061973/doc4.xml","form_type":"4"}},{"id":2080874,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-12-19T22:01:33.000Z","date":"2022-12-16","kind":"exercise","acquired":true,"shares":783,"price":2.8968,"value":2268.1944,"ownership":{"direct":true},"balance_after":27604,"source":{"system":"sec-edgar","filing":"0001209191-22-061973","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122061973/doc4.xml","form_type":"4"}},{"id":2080873,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-12-19T22:01:33.000Z","date":"2022-12-16","kind":"sale","acquired":false,"shares":1429,"price":19.1204,"value":27323.0516,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 13, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $18.88 to $19.82, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":26821,"source":{"system":"sec-edgar","filing":"0001209191-22-061973","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122061973/doc4.xml","form_type":"4"}},{"id":2080872,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-12-19T22:01:33.000Z","date":"2022-12-16","kind":"exercise","acquired":true,"shares":1429,"price":2.8968,"value":4139.5272,"ownership":{"direct":true},"balance_after":28250,"source":{"system":"sec-edgar","filing":"0001209191-22-061973","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122061973/doc4.xml","form_type":"4"}},{"id":2086054,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Options (right to buy)","published_at":"2022-12-14T21:08:34.000Z","date":"2022-12-13","kind":"exercise","acquired":false,"shares":1078,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/4 of the shares subject to the option vested on March 12, 2021, and 1/48 of the shares vest monthly thereafter."}],"balance_after":8639,"derivative":{"exercise_price":6.3728,"expiration_date":"2030-03-31","underlying":"Class A Common Stock","underlying_shares":1078},"source":{"system":"sec-edgar","filing":"0001209191-22-061178","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122061178/doc4.xml","form_type":"4"}},{"id":2086053,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-12-14T21:08:34.000Z","date":"2022-12-13","kind":"exercise","acquired":false,"shares":11733,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4 of the shares subject to the option vested on May 13, 2022, and 1/48 of the shares vest monthly thereafter."}],"balance_after":65384,"derivative":{"exercise_price":11,"expiration_date":"2031-05-12","underlying":"Class A Common Stock","underlying_shares":11733},"source":{"system":"sec-edgar","filing":"0001209191-22-061178","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122061178/doc4.xml","form_type":"4"}},{"id":2086052,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Options (right to buy)","published_at":"2022-12-14T21:08:34.000Z","date":"2022-12-12","kind":"exercise","acquired":false,"shares":6900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4 of the shares subject to the option vested on May 13, 2022, and 1/48 of the shares vest monthly thereafter."}],"balance_after":77117,"derivative":{"exercise_price":11,"expiration_date":"2031-05-12","underlying":"Class A Common Stock","underlying_shares":6900},"source":{"system":"sec-edgar","filing":"0001209191-22-061178","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122061178/doc4.xml","form_type":"4"}},{"id":2086051,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-12-14T21:08:34.000Z","date":"2022-12-13","kind":"sale","acquired":false,"shares":1078,"price":18.19,"value":19608.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 13, 2022."}],"balance_after":26821,"source":{"system":"sec-edgar","filing":"0001209191-22-061178","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122061178/doc4.xml","form_type":"4"}},{"id":2086050,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-12-14T21:08:34.000Z","date":"2022-12-13","kind":"exercise","acquired":true,"shares":1078,"price":6.3728,"value":6869.8784,"ownership":{"direct":true},"balance_after":27899,"source":{"system":"sec-edgar","filing":"0001209191-22-061178","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122061178/doc4.xml","form_type":"4"}},{"id":2086049,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-12-14T21:08:34.000Z","date":"2022-12-13","kind":"sale","acquired":false,"shares":11733,"price":18.2767,"value":214440.5211,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 13, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $18.09 to $18.92, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":26821,"source":{"system":"sec-edgar","filing":"0001209191-22-061178","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122061178/doc4.xml","form_type":"4"}},{"id":2086048,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-12-14T21:08:34.000Z","date":"2022-12-13","kind":"exercise","acquired":true,"shares":11733,"price":11,"value":129063.0,"ownership":{"direct":true},"balance_after":38554,"source":{"system":"sec-edgar","filing":"0001209191-22-061178","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122061178/doc4.xml","form_type":"4"}},{"id":2086047,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-12-14T21:08:34.000Z","date":"2022-12-12","kind":"sale","acquired":false,"shares":6900,"price":18.2498,"value":125923.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 13, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.41, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":26821,"source":{"system":"sec-edgar","filing":"0001209191-22-061178","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122061178/doc4.xml","form_type":"4"}},{"id":2086046,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-12-14T21:08:34.000Z","date":"2022-12-12","kind":"exercise","acquired":true,"shares":6900,"price":11,"value":75900.0,"ownership":{"direct":true},"balance_after":33721,"source":{"system":"sec-edgar","filing":"0001209191-22-061178","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122061178/doc4.xml","form_type":"4"}},{"id":2091861,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-12-08T21:06:18.000Z","date":"2022-12-07","kind":"sale","acquired":false,"shares":494,"price":16.47,"value":8136.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 13, 2022."}],"balance_after":26821,"source":{"system":"sec-edgar","filing":"0001209191-22-060331","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122060331/doc4.xml","form_type":"4"}},{"id":2108141,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-11-21T21:08:14.000Z","date":"2022-11-17","kind":"exercise","acquired":false,"shares":2211,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/4 of the shares subject to the option vested on December 16, 2021, and 1/48 of the shares vest monthly thereafter."}],"balance_after":38013,"derivative":{"exercise_price":2.8968,"expiration_date":"2030-12-15","underlying":"Class A Common Stock","underlying_shares":2211},"source":{"system":"sec-edgar","filing":"0001209191-22-058095","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122058095/doc4.xml","form_type":"4"}},{"id":2108140,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-11-21T21:08:14.000Z","date":"2022-11-17","kind":"exercise","acquired":false,"shares":1078,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4 of the shares subject to the option vested on March 12, 2021, and 1/48 of the shares vest monthly thereafter."}],"balance_after":9717,"derivative":{"exercise_price":6.3728,"expiration_date":"2030-03-31","underlying":"Class A Common Stock","underlying_shares":1078},"source":{"system":"sec-edgar","filing":"0001209191-22-058095","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122058095/doc4.xml","form_type":"4"}},{"id":2108139,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-11-21T21:08:14.000Z","date":"2022-11-17","kind":"sale","acquired":false,"shares":2211,"price":15.8436,"value":35030.1996,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 13, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $15.57 to $16.08, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":27315,"source":{"system":"sec-edgar","filing":"0001209191-22-058095","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122058095/doc4.xml","form_type":"4"}},{"id":2108138,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-11-21T21:08:14.000Z","date":"2022-11-17","kind":"exercise","acquired":true,"shares":2211,"price":2.8968,"value":6404.8248,"ownership":{"direct":true},"balance_after":29526,"source":{"system":"sec-edgar","filing":"0001209191-22-058095","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122058095/doc4.xml","form_type":"4"}},{"id":2108137,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-11-21T21:08:14.000Z","date":"2022-11-17","kind":"sale","acquired":false,"shares":1078,"price":15.8606,"value":17097.7268,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 13, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $15.45 to $16.13, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":27315,"source":{"system":"sec-edgar","filing":"0001209191-22-058095","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122058095/doc4.xml","form_type":"4"}},{"id":2108136,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-11-21T21:08:14.000Z","date":"2022-11-17","kind":"exercise","acquired":true,"shares":1078,"price":6.3728,"value":6869.8784,"ownership":{"direct":true},"balance_after":28393,"source":{"system":"sec-edgar","filing":"0001209191-22-058095","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122058095/doc4.xml","form_type":"4"}},{"id":2119688,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-11-10T21:04:58.000Z","date":"2022-11-09","kind":"sale","acquired":false,"shares":494,"price":16.54,"value":8170.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 13, 2022."}],"balance_after":27315,"source":{"system":"sec-edgar","filing":"0001209191-22-056364","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122056364/doc4.xml","form_type":"4"}},{"id":2134003,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Options (right to buy)","published_at":"2022-10-20T20:37:51.000Z","date":"2022-10-18","kind":"exercise","acquired":false,"shares":5300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"1/4 of the shares subject to the option vested on May 13, 2022, and 1/48 of the shares vest monthly thereafter."}],"balance_after":84017,"derivative":{"exercise_price":11,"expiration_date":"2031-05-12","underlying":"Class A Common Stock","underlying_shares":5300},"source":{"system":"sec-edgar","filing":"0001209191-22-054192","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122054192/doc4.xml","form_type":"4"}},{"id":2134002,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-10-20T20:37:51.000Z","date":"2022-10-18","kind":"exercise","acquired":false,"shares":2212,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"1/4 of the shares subject to the option vested on December 16, 2021, and 1/48 of the shares vest monthly thereafter."}],"balance_after":40224,"derivative":{"exercise_price":2.8968,"expiration_date":"2030-12-15","underlying":"Class A Common Stock","underlying_shares":2212},"source":{"system":"sec-edgar","filing":"0001209191-22-054192","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122054192/doc4.xml","form_type":"4"}},{"id":2134001,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-10-20T20:37:51.000Z","date":"2022-10-18","kind":"exercise","acquired":false,"shares":1078,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/4 of the shares subject to the option vested on March 12, 2021, and 1/48 of the shares vest monthly thereafter."}],"balance_after":10795,"derivative":{"exercise_price":6.3728,"expiration_date":"2030-03-31","underlying":"Class A Common Stock","underlying_shares":1078},"source":{"system":"sec-edgar","filing":"0001209191-22-054192","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122054192/doc4.xml","form_type":"4"}},{"id":2134000,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-10-20T20:37:51.000Z","date":"2022-10-18","kind":"sale","acquired":false,"shares":2,"price":20.3,"value":40.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 13, 2022."}],"balance_after":27809,"source":{"system":"sec-edgar","filing":"0001209191-22-054192","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122054192/doc4.xml","form_type":"4"}},{"id":2133999,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-10-20T20:37:51.000Z","date":"2022-10-18","kind":"exercise","acquired":true,"shares":2,"price":11,"value":22.0,"ownership":{"direct":true},"balance_after":27811,"source":{"system":"sec-edgar","filing":"0001209191-22-054192","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122054192/doc4.xml","form_type":"4"}},{"id":2133998,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-10-20T20:37:51.000Z","date":"2022-10-18","kind":"sale","acquired":false,"shares":5298,"price":19.4159,"value":102865.4382,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 13, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $19.05 to $19.93, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":27809,"source":{"system":"sec-edgar","filing":"0001209191-22-054192","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122054192/doc4.xml","form_type":"4"}},{"id":2133997,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-10-20T20:37:51.000Z","date":"2022-10-18","kind":"exercise","acquired":true,"shares":5298,"price":11,"value":58278.0,"ownership":{"direct":true},"balance_after":33107,"source":{"system":"sec-edgar","filing":"0001209191-22-054192","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122054192/doc4.xml","form_type":"4"}},{"id":2133996,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-10-20T20:37:51.000Z","date":"2022-10-18","kind":"sale","acquired":false,"shares":2212,"price":19.3865,"value":42882.938,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 13, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $19.04 to $19.89, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":27809,"source":{"system":"sec-edgar","filing":"0001209191-22-054192","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122054192/doc4.xml","form_type":"4"}},{"id":2133995,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-10-20T20:37:51.000Z","date":"2022-10-18","kind":"exercise","acquired":true,"shares":2212,"price":2.8968,"value":6407.7216,"ownership":{"direct":true},"balance_after":30021,"source":{"system":"sec-edgar","filing":"0001209191-22-054192","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122054192/doc4.xml","form_type":"4"}},{"id":2133994,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-10-20T20:37:51.000Z","date":"2022-10-18","kind":"sale","acquired":false,"shares":1078,"price":19.4304,"value":20945.9712,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 13, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $19.07 to $19.89, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":27809,"source":{"system":"sec-edgar","filing":"0001209191-22-054192","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122054192/doc4.xml","form_type":"4"}},{"id":2133993,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-10-20T20:37:51.000Z","date":"2022-10-18","kind":"exercise","acquired":true,"shares":1078,"price":6.3728,"value":6869.8784,"ownership":{"direct":true},"balance_after":28887,"source":{"system":"sec-edgar","filing":"0001209191-22-054192","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122054192/doc4.xml","form_type":"4"}},{"id":2140916,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-10-06T20:04:57.000Z","date":"2022-10-05","kind":"sale","acquired":false,"shares":988,"price":21.64,"value":21380.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 13, 2022."}],"balance_after":27809,"source":{"system":"sec-edgar","filing":"0001209191-22-052972","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122052972/doc4.xml","form_type":"4"}},{"id":2152492,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Options (right to buy)","published_at":"2022-09-22T20:06:39.000Z","date":"2022-09-21","kind":"exercise","acquired":false,"shares":1174,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"1/4 of the shares subject to the option vested on May 13, 2022, and 1/48 of the shares vest monthly thereafter."}],"balance_after":89317,"derivative":{"exercise_price":11,"expiration_date":"2031-05-12","underlying":"Class A Common Stock","underlying_shares":1174},"source":{"system":"sec-edgar","filing":"0001209191-22-051002","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122051002/doc4.xml","form_type":"4"}},{"id":2152491,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Options (right to buy)","published_at":"2022-09-22T20:06:39.000Z","date":"2022-09-20","kind":"exercise","acquired":false,"shares":12426,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"1/4 of the shares subject to the option vested on May 13, 2022, and 1/48 of the shares vest monthly thereafter."}],"balance_after":90491,"derivative":{"exercise_price":11,"expiration_date":"2031-05-12","underlying":"Class A Common Stock","underlying_shares":12426},"source":{"system":"sec-edgar","filing":"0001209191-22-051002","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122051002/doc4.xml","form_type":"4"}},{"id":2152490,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-09-22T20:06:39.000Z","date":"2022-09-20","kind":"exercise","acquired":false,"shares":2162,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"1/4 of the shares subject to the option vested on December 16, 2021, and 1/48 of the shares vest monthly thereafter."}],"balance_after":42436,"derivative":{"exercise_price":2.8968,"expiration_date":"2030-12-15","underlying":"Class A Common Stock","underlying_shares":2162},"source":{"system":"sec-edgar","filing":"0001209191-22-051002","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122051002/doc4.xml","form_type":"4"}},{"id":2152489,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-09-22T20:06:39.000Z","date":"2022-09-20","kind":"exercise","acquired":false,"shares":1078,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"1/4 of the shares subject to the option vested on March 12, 2021, and 1/48 of the shares vest monthly thereafter."}],"balance_after":11873,"derivative":{"exercise_price":6.3728,"expiration_date":"2030-03-31","underlying":"Class A Common Stock","underlying_shares":1078},"source":{"system":"sec-edgar","filing":"0001209191-22-051002","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122051002/doc4.xml","form_type":"4"}},{"id":2152488,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-09-22T20:06:39.000Z","date":"2022-09-21","kind":"sale","acquired":false,"shares":264,"price":22.3465,"value":5899.476,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 13, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $22.09 to $22.62, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":28797,"source":{"system":"sec-edgar","filing":"0001209191-22-051002","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122051002/doc4.xml","form_type":"4"}},{"id":2152487,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-09-22T20:06:39.000Z","date":"2022-09-21","kind":"exercise","acquired":true,"shares":264,"price":11,"value":2904.0,"ownership":{"direct":true},"balance_after":29061,"source":{"system":"sec-edgar","filing":"0001209191-22-051002","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122051002/doc4.xml","form_type":"4"}},{"id":2152486,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-09-22T20:06:39.000Z","date":"2022-09-21","kind":"sale","acquired":false,"shares":910,"price":21.1255,"value":19224.205,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 13, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $20.74 to $21.58, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":28797,"source":{"system":"sec-edgar","filing":"0001209191-22-051002","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122051002/doc4.xml","form_type":"4"}},{"id":2152485,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-09-22T20:06:39.000Z","date":"2022-09-21","kind":"exercise","acquired":true,"shares":910,"price":11,"value":10010.0,"ownership":{"direct":true},"balance_after":29707,"source":{"system":"sec-edgar","filing":"0001209191-22-051002","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122051002/doc4.xml","form_type":"4"}},{"id":2152484,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-09-22T20:06:39.000Z","date":"2022-09-20","kind":"sale","acquired":false,"shares":10112,"price":20.8045,"value":210375.104,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 13, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $20.60 to $21.06, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":28797,"source":{"system":"sec-edgar","filing":"0001209191-22-051002","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122051002/doc4.xml","form_type":"4"}},{"id":2152483,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-09-22T20:06:39.000Z","date":"2022-09-20","kind":"exercise","acquired":true,"shares":10112,"price":11,"value":111232.0,"ownership":{"direct":true},"balance_after":38909,"source":{"system":"sec-edgar","filing":"0001209191-22-051002","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122051002/doc4.xml","form_type":"4"}},{"id":2152482,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-09-22T20:06:39.000Z","date":"2022-09-20","kind":"sale","acquired":false,"shares":2314,"price":20.241,"value":46837.674,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 13, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $19.68 to $20.58, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":28797,"source":{"system":"sec-edgar","filing":"0001209191-22-051002","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122051002/doc4.xml","form_type":"4"}},{"id":2152481,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-09-22T20:06:39.000Z","date":"2022-09-20","kind":"exercise","acquired":true,"shares":2314,"price":11,"value":25454.0,"ownership":{"direct":true},"balance_after":31111,"source":{"system":"sec-edgar","filing":"0001209191-22-051002","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122051002/doc4.xml","form_type":"4"}},{"id":2152480,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-09-22T20:06:39.000Z","date":"2022-09-20","kind":"sale","acquired":false,"shares":334,"price":20.9153,"value":6985.7102,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 13, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $20.87 to $21.00, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":28797,"source":{"system":"sec-edgar","filing":"0001209191-22-051002","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122051002/doc4.xml","form_type":"4"}},{"id":2152479,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-09-22T20:06:39.000Z","date":"2022-09-20","kind":"exercise","acquired":true,"shares":334,"price":2.8968,"value":967.5312,"ownership":{"direct":true},"balance_after":29131,"source":{"system":"sec-edgar","filing":"0001209191-22-051002","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122051002/doc4.xml","form_type":"4"}},{"id":2152478,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-09-22T20:06:39.000Z","date":"2022-09-20","kind":"sale","acquired":false,"shares":1828,"price":20.4757,"value":37429.5796,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 13, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $19.85 to $20.84, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":28797,"source":{"system":"sec-edgar","filing":"0001209191-22-051002","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122051002/doc4.xml","form_type":"4"}},{"id":2152477,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-09-22T20:06:39.000Z","date":"2022-09-20","kind":"exercise","acquired":true,"shares":1828,"price":2.8968,"value":5295.3504,"ownership":{"direct":true},"balance_after":30625,"source":{"system":"sec-edgar","filing":"0001209191-22-051002","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122051002/doc4.xml","form_type":"4"}},{"id":2152476,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-09-22T20:06:39.000Z","date":"2022-09-20","kind":"sale","acquired":false,"shares":100,"price":21,"value":2100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 13, 2022."}],"balance_after":28797,"source":{"system":"sec-edgar","filing":"0001209191-22-051002","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122051002/doc4.xml","form_type":"4"}},{"id":2152475,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-09-22T20:06:39.000Z","date":"2022-09-20","kind":"exercise","acquired":true,"shares":100,"price":6.3728,"value":637.28,"ownership":{"direct":true},"balance_after":28897,"source":{"system":"sec-edgar","filing":"0001209191-22-051002","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122051002/doc4.xml","form_type":"4"}},{"id":2152474,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-09-22T20:06:39.000Z","date":"2022-09-20","kind":"sale","acquired":false,"shares":978,"price":20.5442,"value":20092.2276,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 13, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $19.96 to $20.90, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":28797,"source":{"system":"sec-edgar","filing":"0001209191-22-051002","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122051002/doc4.xml","form_type":"4"}},{"id":2152473,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-09-22T20:06:39.000Z","date":"2022-09-20","kind":"exercise","acquired":true,"shares":978,"price":6.3728,"value":6232.5984,"ownership":{"direct":true},"balance_after":29775,"source":{"system":"sec-edgar","filing":"0001209191-22-051002","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122051002/doc4.xml","form_type":"4"}},{"id":2162841,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-09-08T20:41:23.000Z","date":"2022-09-07","kind":"sale","acquired":false,"shares":988,"price":18.63,"value":18406.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 13, 2022."}],"balance_after":28797,"source":{"system":"sec-edgar","filing":"0001209191-22-049176","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122049176/doc4.xml","form_type":"4"}},{"id":2175706,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Options (right to buy)","published_at":"2022-08-23T20:15:26.000Z","date":"2022-08-22","kind":"exercise","acquired":false,"shares":1630,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"1/4 of the shares subject to the option vest on May 13, 2022, and 1/48 of the shares vest monthly thereafter."}],"balance_after":102917,"derivative":{"exercise_price":11,"expiration_date":"2031-05-12","underlying":"Class A Common Stock","underlying_shares":1630},"source":{"system":"sec-edgar","filing":"0001209191-22-047172","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122047172/doc4.xml","form_type":"4"}},{"id":2175705,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Options (right to buy)","published_at":"2022-08-23T20:15:26.000Z","date":"2022-08-19","kind":"exercise","acquired":false,"shares":3670,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"1/4 of the shares subject to the option vest on May 13, 2022, and 1/48 of the shares vest monthly thereafter."}],"balance_after":104547,"derivative":{"exercise_price":11,"expiration_date":"2031-05-12","underlying":"Class A Common Stock","underlying_shares":3670},"source":{"system":"sec-edgar","filing":"0001209191-22-047172","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122047172/doc4.xml","form_type":"4"}},{"id":2175704,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-08-23T20:15:26.000Z","date":"2022-08-19","kind":"exercise","acquired":false,"shares":2161,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"1/4 of the shares subject to the option vest on December 16, 2021, and 1/48 of the shares vest monthly thereafter."}],"balance_after":44598,"derivative":{"exercise_price":2.8968,"expiration_date":"2030-12-15","underlying":"Class A Common Stock","underlying_shares":2161},"source":{"system":"sec-edgar","filing":"0001209191-22-047172","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122047172/doc4.xml","form_type":"4"}},{"id":2175703,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-08-23T20:15:26.000Z","date":"2022-08-19","kind":"exercise","acquired":false,"shares":1078,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"1/4 of the shares subject to the option vested on March 12, 2021, and 1/48 of the shares vest monthly thereafter."}],"balance_after":12951,"derivative":{"exercise_price":6.3728,"expiration_date":"2030-03-31","underlying":"Class A Common Stock","underlying_shares":1078},"source":{"system":"sec-edgar","filing":"0001209191-22-047172","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122047172/doc4.xml","form_type":"4"}},{"id":2175702,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-08-23T20:15:26.000Z","date":"2022-08-22","kind":"sale","acquired":false,"shares":600,"price":19.6457,"value":11787.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 13, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $19.45 to $19.91, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":29785,"source":{"system":"sec-edgar","filing":"0001209191-22-047172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122047172/doc4.xml","form_type":"4"}},{"id":2175701,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-08-23T20:15:26.000Z","date":"2022-08-22","kind":"exercise","acquired":true,"shares":600,"price":11,"value":6600.0,"ownership":{"direct":true},"balance_after":30385,"source":{"system":"sec-edgar","filing":"0001209191-22-047172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122047172/doc4.xml","form_type":"4"}},{"id":2175700,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-08-23T20:15:26.000Z","date":"2022-08-22","kind":"sale","acquired":false,"shares":1030,"price":18.4241,"value":18976.823,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 13, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $18.20 to $18.75, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":29785,"source":{"system":"sec-edgar","filing":"0001209191-22-047172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122047172/doc4.xml","form_type":"4"}},{"id":2175699,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-08-23T20:15:26.000Z","date":"2022-08-22","kind":"exercise","acquired":true,"shares":1030,"price":11,"value":11330.0,"ownership":{"direct":true},"balance_after":30815,"source":{"system":"sec-edgar","filing":"0001209191-22-047172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122047172/doc4.xml","form_type":"4"}},{"id":2175698,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-08-23T20:15:26.000Z","date":"2022-08-19","kind":"sale","acquired":false,"shares":904,"price":19.8055,"value":17904.172,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 13, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $19.56 to $20.21, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":29785,"source":{"system":"sec-edgar","filing":"0001209191-22-047172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122047172/doc4.xml","form_type":"4"}},{"id":2175697,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-08-23T20:15:26.000Z","date":"2022-08-19","kind":"exercise","acquired":true,"shares":904,"price":11,"value":9944.0,"ownership":{"direct":true},"balance_after":30689,"source":{"system":"sec-edgar","filing":"0001209191-22-047172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122047172/doc4.xml","form_type":"4"}},{"id":2175696,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-08-23T20:15:26.000Z","date":"2022-08-19","kind":"sale","acquired":false,"shares":2766,"price":18.6114,"value":51479.1324,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 13, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $18.24 to $19.23, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":29785,"source":{"system":"sec-edgar","filing":"0001209191-22-047172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122047172/doc4.xml","form_type":"4"}},{"id":2175695,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-08-23T20:15:26.000Z","date":"2022-08-19","kind":"exercise","acquired":true,"shares":2766,"price":11,"value":30426.0,"ownership":{"direct":true},"balance_after":32551,"source":{"system":"sec-edgar","filing":"0001209191-22-047172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122047172/doc4.xml","form_type":"4"}},{"id":2175694,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-08-23T20:15:26.000Z","date":"2022-08-19","kind":"sale","acquired":false,"shares":1451,"price":19.8685,"value":28829.1935,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 13, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $19.70 to $20.02, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":29785,"source":{"system":"sec-edgar","filing":"0001209191-22-047172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122047172/doc4.xml","form_type":"4"}},{"id":2175693,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-08-23T20:15:26.000Z","date":"2022-08-19","kind":"exercise","acquired":true,"shares":1451,"price":2.8968,"value":4203.2568,"ownership":{"direct":true},"balance_after":31236,"source":{"system":"sec-edgar","filing":"0001209191-22-047172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122047172/doc4.xml","form_type":"4"}},{"id":2175692,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-08-23T20:15:26.000Z","date":"2022-08-19","kind":"sale","acquired":false,"shares":710,"price":18.9312,"value":13441.152,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 13, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $18.50 to $19.30, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":29785,"source":{"system":"sec-edgar","filing":"0001209191-22-047172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122047172/doc4.xml","form_type":"4"}},{"id":2175691,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-08-23T20:15:26.000Z","date":"2022-08-19","kind":"exercise","acquired":true,"shares":710,"price":2.8968,"value":2056.728,"ownership":{"direct":true},"balance_after":30495,"source":{"system":"sec-edgar","filing":"0001209191-22-047172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122047172/doc4.xml","form_type":"4"}},{"id":2175690,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-08-23T20:15:26.000Z","date":"2022-08-19","kind":"sale","acquired":false,"shares":700,"price":19.7607,"value":13832.49,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 13, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $19.56 to $20.00, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":29785,"source":{"system":"sec-edgar","filing":"0001209191-22-047172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122047172/doc4.xml","form_type":"4"}},{"id":2175689,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-08-23T20:15:26.000Z","date":"2022-08-19","kind":"exercise","acquired":true,"shares":700,"price":6.3728,"value":4460.96,"ownership":{"direct":true},"balance_after":30485,"source":{"system":"sec-edgar","filing":"0001209191-22-047172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122047172/doc4.xml","form_type":"4"}},{"id":2175688,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-08-23T20:15:26.000Z","date":"2022-08-19","kind":"sale","acquired":false,"shares":378,"price":18.8854,"value":7138.6812,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 13, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $18.49 to $19.24, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":29785,"source":{"system":"sec-edgar","filing":"0001209191-22-047172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122047172/doc4.xml","form_type":"4"}},{"id":2175687,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-08-23T20:15:26.000Z","date":"2022-08-19","kind":"exercise","acquired":true,"shares":378,"price":6.3728,"value":2408.9184,"ownership":{"direct":true},"balance_after":30163,"source":{"system":"sec-edgar","filing":"0001209191-22-047172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122047172/doc4.xml","form_type":"4"}},{"id":2175686,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-08-23T20:15:26.000Z","date":"2022-08-19","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Class A Common Stock underlying the restricted stock units (\"RSUs\") under Issuer's 2021 Equity Incentive Plan. One-third of the RSUs vest on August 20, 2023, rounded to the nearest whole share, and the remaining RSUs vest on August 20, 2024, subject to the Reporting Person's continuous service through each vesting date."}],"balance_after":29785,"source":{"system":"sec-edgar","filing":"0001209191-22-047172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122047172/doc4.xml","form_type":"4"}},{"id":2194177,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-08-04T20:07:33.000Z","date":"2022-08-03","kind":"sale","acquired":false,"shares":988,"price":16.81,"value":16608.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 13, 2022."}],"balance_after":17285,"source":{"system":"sec-edgar","filing":"0001209191-22-044412","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122044412/doc4.xml","form_type":"4"}},{"id":2204365,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-07-20T20:08:47.000Z","date":"2022-07-19","kind":"exercise","acquired":false,"shares":6054,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/4 of the shares subject to the option vest on December 16, 2021, and 1/48 of the shares vest monthly thereafter."}],"balance_after":46759,"derivative":{"exercise_price":2.8968,"expiration_date":"2030-12-15","underlying":"Class A Common Stock","underlying_shares":6054},"source":{"system":"sec-edgar","filing":"0001209191-22-042675","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122042675/doc4.xml","form_type":"4"}},{"id":2204364,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-07-20T20:08:47.000Z","date":"2022-07-19","kind":"exercise","acquired":false,"shares":5390,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4 of the shares subject to the option vested on March 12, 2021, and 1/48 of the shares vest monthly thereafter."}],"balance_after":14029,"derivative":{"exercise_price":6.3728,"expiration_date":"2030-03-31","underlying":"Class A Common Stock","underlying_shares":5390},"source":{"system":"sec-edgar","filing":"0001209191-22-042675","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122042675/doc4.xml","form_type":"4"}},{"id":2204363,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-07-20T20:08:47.000Z","date":"2022-07-19","kind":"sale","acquired":false,"shares":8,"price":16.545,"value":132.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 13, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $16.53 to $16.56, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":18273,"source":{"system":"sec-edgar","filing":"0001209191-22-042675","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122042675/doc4.xml","form_type":"4"}},{"id":2204362,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-07-20T20:08:47.000Z","date":"2022-07-19","kind":"exercise","acquired":true,"shares":8,"price":2.8968,"value":23.1744,"ownership":{"direct":true},"balance_after":18281,"source":{"system":"sec-edgar","filing":"0001209191-22-042675","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122042675/doc4.xml","form_type":"4"}},{"id":2204361,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-07-20T20:08:47.000Z","date":"2022-07-19","kind":"sale","acquired":false,"shares":6046,"price":16.0123,"value":96810.3658,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 13, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $15.46 to $16.45, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":18273,"source":{"system":"sec-edgar","filing":"0001209191-22-042675","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122042675/doc4.xml","form_type":"4"}},{"id":2204360,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-07-20T20:08:47.000Z","date":"2022-07-19","kind":"exercise","acquired":true,"shares":6046,"price":2.8968,"value":17514.0528,"ownership":{"direct":true},"balance_after":24319,"source":{"system":"sec-edgar","filing":"0001209191-22-042675","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122042675/doc4.xml","form_type":"4"}},{"id":2204359,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-07-20T20:08:47.000Z","date":"2022-07-19","kind":"sale","acquired":false,"shares":6,"price":16.55,"value":99.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 13, 2022."}],"balance_after":18273,"source":{"system":"sec-edgar","filing":"0001209191-22-042675","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122042675/doc4.xml","form_type":"4"}},{"id":2204358,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-07-20T20:08:47.000Z","date":"2022-07-19","kind":"exercise","acquired":true,"shares":6,"price":6.3728,"value":38.2368,"ownership":{"direct":true},"balance_after":18279,"source":{"system":"sec-edgar","filing":"0001209191-22-042675","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122042675/doc4.xml","form_type":"4"}},{"id":2204357,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-07-20T20:08:47.000Z","date":"2022-07-19","kind":"sale","acquired":false,"shares":5384,"price":16.0158,"value":86229.0672,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 13, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $15.46 to $16.45, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":18273,"source":{"system":"sec-edgar","filing":"0001209191-22-042675","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122042675/doc4.xml","form_type":"4"}},{"id":2204356,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-07-20T20:08:47.000Z","date":"2022-07-19","kind":"exercise","acquired":true,"shares":5384,"price":6.3728,"value":34311.1552,"ownership":{"direct":true},"balance_after":23657,"source":{"system":"sec-edgar","filing":"0001209191-22-042675","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122042675/doc4.xml","form_type":"4"}},{"id":2206731,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-07-15T20:41:20.000Z","date":"2022-07-14","kind":"exercise","acquired":false,"shares":6354,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4 of the shares subject to the option vest on December 16, 2021, and 1/48 of the shares vest monthly thereafter."}],"balance_after":52813,"derivative":{"exercise_price":2.8968,"expiration_date":"2030-12-15","underlying":"Class A Common Stock","underlying_shares":6354},"source":{"system":"sec-edgar","filing":"0001209191-22-042255","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122042255/doc4.xml","form_type":"4"}},{"id":2206730,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-07-15T20:41:20.000Z","date":"2022-07-14","kind":"sale","acquired":false,"shares":2750,"price":15.1744,"value":41729.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 13, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.57, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":18273,"source":{"system":"sec-edgar","filing":"0001209191-22-042255","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122042255/doc4.xml","form_type":"4"}},{"id":2206729,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-07-15T20:41:20.000Z","date":"2022-07-14","kind":"sale","acquired":false,"shares":6354,"price":15.1297,"value":96134.1138,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 13, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.55, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":21023,"source":{"system":"sec-edgar","filing":"0001209191-22-042255","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122042255/doc4.xml","form_type":"4"}},{"id":2206728,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-07-15T20:41:20.000Z","date":"2022-07-14","kind":"exercise","acquired":true,"shares":6354,"price":2.8968,"value":18406.2672,"ownership":{"direct":true},"balance_after":27377,"source":{"system":"sec-edgar","filing":"0001209191-22-042255","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122042255/doc4.xml","form_type":"4"}},{"id":2209010,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-07-11T20:04:55.000Z","date":"2022-07-07","kind":"exercise","acquired":false,"shares":3514,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4 of the shares subject to the option vest on December 16, 2021, and 1/48 of the shares vest monthly thereafter."}],"balance_after":59167,"derivative":{"exercise_price":2.8968,"expiration_date":"2030-12-15","underlying":"Class A Common Stock","underlying_shares":3514},"source":{"system":"sec-edgar","filing":"0001209191-22-041771","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122041771/doc4.xml","form_type":"4"}},{"id":2209009,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-07-11T20:04:55.000Z","date":"2022-07-07","kind":"exercise","acquired":false,"shares":3487,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the shares subject to the option vested on March 12, 2021, and 1/48 of the shares vest monthly thereafter."}],"balance_after":19419,"derivative":{"exercise_price":6.3728,"expiration_date":"2030-03-31","underlying":"Class A Common Stock","underlying_shares":3487},"source":{"system":"sec-edgar","filing":"0001209191-22-041771","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122041771/doc4.xml","form_type":"4"}},{"id":2209008,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-07-11T20:04:55.000Z","date":"2022-07-07","kind":"sale","acquired":false,"shares":2665,"price":15.0297,"value":40054.1505,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 13, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.37, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":21023,"source":{"system":"sec-edgar","filing":"0001209191-22-041771","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122041771/doc4.xml","form_type":"4"}},{"id":2209007,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":75505,"kind":"person","name":"Curley Joanne","position":1,"cik":"0001857670","reported_name":"Curley Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A Common Stock","published_at":"2022-07-11T20:04:55.000Z","date":"2022-07-07","kind":"sale","acquired":false,"shares":3514,"price":15.0764,"value":52978.4696,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 13, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.37, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":23688,"source":{"system":"sec-edgar","filing":"0001209191-22-041771","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122041771/doc4.xml","form_type":"4"}}],"next_cursor":"2022-07-11T20:04:55.000000Z,2209007"}